Matthews International (MATW) Q1 2025 earnings summary

Executive summary

• Q1 FY2025 sales declined to $401.8M from $450.0M year-over-year, with a net loss of $3.5M ($0.11/share) and adjusted EBITDA of $40.0M, both down from prior year, mainly due to declines in Industrial Technologies and Memorialization segments.

• Announced the sale of SGK Brand Solutions for $250M cash, $50M preferred equity, and 40% common equity in a new entity, with proceeds earmarked for debt reduction and regulatory filings underway.

• Achieved a favorable arbitration ruling confirming rights to market and sell proprietary dry battery electrode (DBE) technology, resolving a long-standing dispute with Tesla and enabling renewed commercialization.

• Cost reduction initiatives are progressing, targeting at least $50M in annual savings, with $25–$30M run rate expected by year-end.

• Fiscal Q1 2025 results were generally in line with expectations, supporting maintained full-year outlook pending SGK transaction completion.

Financial highlights

• Q1 FY2025 net loss was $3.5M ($0.11/share) versus $2.3M ($0.07/share) loss a year ago; adjusted net income was $4.3M ($0.14/share) compared to $11.3M ($0.37/share) last year.

• Consolidated sales were $401.8M, down 10.7% from $450.0M year-over-year.

• Adjusted EBITDA was $40.0M, down from $45.5M a year ago.

• Gross margin improved to 31.3% from 29.4% year-over-year.

• Cash flow used in operating activities was $25.0M, slightly improved from $27.3M last year.

Outlook and guidance

• Fiscal 2025 adjusted EBITDA guidance remains at $205–$215M, contingent on SGK transaction timing and including SGK for the full year.

• Cost reduction programs are on track to deliver up to $50M in annual savings, with $25–$30M run rate by year-end and full realization by end of next fiscal year.

• Net leverage expected to improve from 3.9x to below 3x post-SGK transaction, with further deleveraging planned.

• SGK Brand Solutions divestiture expected to close by mid-2025, with proceeds to be used for debt reduction and strategic investments.

• Capital expenditures for FY2025 estimated at $50M–$60M, funded by operating cash flow.